The adrenergic antagonist improved near vision in adults with presbyopia, with over 20 hours of improvement from a single administration in the VEGA-3 trial. Medscape Medical News
Tag: News
Sedation-Free Cataract Surgery Feasible for Select Patients
In a retrospective case series, surgical control and safety are maintained without systemic anesthesia, showing feasibility to expand use. Medscape Medical News
Cosmetic Eyelash Extensions Linked to Dry Eye Symptoms
Eye symptoms affect most recipients of lash lifts and extensions, with an independent association with dry eye in an observational study. Medscape Medical News
Insurers Fail to Get Specific on Prior Authorization Reforms
An industry trade group says prior authorization requirements have declined by 11% after last year’s pledge, but the numbers are fuzzy. Medscape Medical News
IDEAYA and Servier’s Eye Cancer Drug Meets Trial Goal, Paving Way for FDA Application
IDEAYA Biosciences and French pharma company Servier said on Monday their combination drug for a type of eye cancer met the main goal of a mid-to-late-stage trial, sending… Reuters Health Information
Should Your Patient Be on Statins? Maybe the Eyes Can Tell
A trial of an AI algorithm that uses retina images to evaluate the risk for atherosclerotic cardiovascular disease demonstrates a high level of accuracy. Medscape Medical News
Treating IgG4-RD: How Far Will B-Cell Drugs Take the Field?
Post hoc analyses of pivotal MITIGATE trial show broad efficacy across patient subgroups with differing organ involvement and clinical characteristics. Medscape Medical News
Docs, Lawsuit Challenge Medicare WISeR Prior Auth Experiment
Doctors in multiple states report unpaid claims and care delays under the new federal program, as a lawsuit seeks answers about AI algorithms and data security. Medscape Medical News
Myopia Numbers Are Rising. Our Response Should Be Too
With myopia affecting 1 in 3 people, eye experts are urging clinicians to act now to slow progression in patients. Medscape Medical News
Immunovant’s Treatment for Eye Disease Fails in Late-stage Trials
Immunovant said on Thursday that its therapy failed to reduce eye bulging when tested in patients with moderate-to-severe thyroid eye disease in two late-stage… Reuters Health Information
The Death of the Medical Fax Is Foretold — Again
Medical offices are sick and tired of faxing, and federal officials agree. But modernization won’t be easy. Medscape Medical News
Viridian Eye Disease Drug Disappoints on Efficacy Despite Trial Success
Viridian Therapeutics’ experimental treatment for thyroid eye disease lagged rivals in efficacy in a late-stage… Reuters Health Information
Kodiak Sciences Eye Drug Succeeds in Late-stage Study
Kodiak Sciences’ experimental drug met the main goal in a late-stage trial. Reuters Health Information
Floaters May Signal Urgent Need for Specialty Attention
The risk for retinal detachment is particularly strong in people with at least 10 floaters, Dutch researchers have found. Medscape Medical News
EyePoint Sues Rival Ocular Therapeutix, Alleging False Claims About Eye Drug
EyePoint filed a lawsuit on Friday accusing rival Ocular Therapeutix of spreading false or misleading information about EyePoint and its lead experimental eye… Reuters Health Information
Paralympic Classification: Making Milano Cortina Fair
For clinicians, knowing the B, LW, and SB class systems helps interpret outcomes and advise athletes on training, equipment choices, and realistic performance expectations. Medscape News Europe
Eye Condition Risk Elevated With Semaglutide, but Still Low
New VA database study is the latest to find a small but significant increased risk for nonarteritic anterior ischemic optic neuropathy. Medscape Medical News
FDA Withdraws Proposal to Prohibit Minors From Tanning Beds
‘Restricting teens’ access to indoor tanning and informing the public about the dangers of indoor tanning are critical to preventing skin cancer,’ AAD President Susan C. Taylor, MD, said. Medscape Medical News
US FDA Declines to Approve Aldeyra’s Eye Disorder Drug, Shares Slump
The U.S. Food and Drug Administration declined to approve Aldeyra Therapeutics’ drug for a type of eye disease, the company said on Tuesday, sending its shares plunging… Reuters Health Information
Change Healthcare Breach Still Affecting Docs, Hospitals
Physicians and hospitals alike are still digging out financially from the impact of the massive Change Healthcare hack in 2024. Medscape Medical News